Evaluation of depression, ti̇redness, sleep disorder, anxiety and quality of life in parki̇nson patients

In this study, it is aimed to evaluate depression, fatigue, sleep disorder, anxiety and quality of life in Parkinsons's patients. At the same time, it is aimed to examine the depression, fatigue, sleep disorder, anxiety and quality of life levels of individuals with Parkinson's disease in terms of gender, age and disease stage variables. In this direction, the research data were collected at Istanbul Bezmialem Vakıf University Hospital between 01.12.2019-01.04.2020. The research was carried out in observational, analytical and cross-sectional models 30 patients with Parkinson's diagnosis and 30 healthy individuals participated in the study. In the collection of data in the study, socio-demographic data form created by the researchers by examining the relevant literature, determining the degree of Parkinson's disease "Combined Parkinson's Disease Rating Scale", individuals' depression "Beck Depression Scale", fatigue "Fatigue Severity Scale", sleep disorder "Pitts Burgh Sleep Quality index", anxiety was evaluated with the "Hamilton Anxiety Scale" and quality of life with the "P-36 Quality of Life Scale-Short Form". Differences between groups were analyzed using Student's t test and ANOVA test and the level of significance was accepted as p <0.05. As a result of the study, it was observed that individuals with Parkinson's disease and healthy individuals differ significantly in levels of depression, fatigue, anxiety and quality of life. While depression, fatigue, anxiety levels of individuals with Parkinson's disease were significantly higher than healthy individuals; quality of life levels are significantly lower. At the same time, depression, fatigue, anxiety and quality of life levels of individuals with Parkinson's disease do not differ according to gender, age and disease stage.